Frontiers in Cardiovascular Medicine

JUNE 5, 2024

BackgroundBehcet's disease (BD) is a systematic vasculitis that affects vessels with various sizes, presenting as venous thrombosis and arterial pseudoaneurysms.

Embolism 52

Embolism Aortic Thrombosis Stent 52

Open Heart

JANUARY 6, 2022

Colchicine, a cheap and widely used anti-inflammatory has shown promise in improving cardiovascular outcomes. Results The use of colchicine in patients who underwent PCI significantly reduced MACE outcomes (risk ratio 0.73 (95% CI 0.61 This has been shown to increase the likelihood of further major adverse cardiovascular events (MACE).

Coronary Artery Disease 52

Coronary Artery Disease Thrombosis Stent Stents 52

Frontiers in Cardiovascular Medicine

JANUARY 29, 2025

Upon removal of its retrieval hook, the filter's legs are intended to expand, forming a stent-like structure that is suitable for long-term residence in the human body. For younger or thrombophilic patients, careful evaluation of the filter's suitability and extended follow-up are crucial to optimize outcomes.

Thrombosis 52

Thrombosis Embolism Stent Stents 52

Dr. Smith's ECG Blog

JANUARY 27, 2024

Old ‘NSTEMI’ A history of coronary artery disease and a stent to the same territory further increases pre-test likelihood of acute coronary occlusion, including in-stent thrombosis. The patient had a history of ‘NSTEMI’ a decade prior, with an RCA stent. Does this change your interpretation?

Chest Pain 117

Chest Pain STEMI Aneurysm Stent 117

Stroke Journal

NOVEMBER 27, 2024

BACKGROUND:Lack of a dedicated thrombectomy device for cerebral venous thrombosis hinders the recanalization ability of endovascular treatment (EVT). Novel NiTi-braided stent retriever (Venous-TD) is a dedicated venous sinus thrombectomy device. Stroke, Volume 56, Issue 1 , Page 5-13, January 1, 2025.

Thrombosis 40

Thrombosis Stent Stents Hemorrhage 40

Stroke: Vascular and Interventional Neurology

OCTOBER 2, 2023

BackgroundProcedural intravenous cangrelor has been proposed as an effective platelet inhibition strategy for stenting in acute ischemic stroke. Safety outcomes included rates of symptomatic intracranial hemorrhage, parenchymal hematoma type 2, petechial hemorrhage, and in‐stent thrombosis. 3.28];P=0.836).

Hemorrhage 40

Hemorrhage Thrombosis Stent Stents 40

American College of Cardiology

FEBRUARY 1, 2025

Cardiovascular medications frequently lead this category, often contributing to adverse clinical outcomes, including emergency department visits and hospitalizations. In recent years, numerous health care challenges have been tackled, some making headlines, while others quietly escalate under the radar – like polypharmacy.

Cardiovascular Disease 40

Cardiovascular Disease Coronary Artery Disease CMS Hospital 40

Stroke: Vascular and Interventional Neurology

NOVEMBER 9, 2023

We therefore aim to characterize the antiplatelet regimens, and associated thromboembolic/hemorrhagic outcomes, utilized in patients with aneurysms treated with PED Shield.MethodsFactors including demographics, comorbidities, rupture status, devices placed, and antiplatelet regimen, among others, were collected.

Embolism 40

Embolism Aneurysm Hemorrhage Stent 40

Dr. Smith's ECG Blog

NOVEMBER 15, 2013

It is important to recognize that coronary thrombosis is dynamic , with spontaneous opening and lysing of the thrombus in the infarct-related artery (we all have endogenous tPA and plasmin to lyse thrombi). It was stented. Silent ischemia as a marker for early unfavorable outcomes in patients with unstable angina.

Chest Pain 52

Chest Pain Thrombosis Myocardial Infarction STEMI 52

Dr. Smith's ECG Blog

NOVEMBER 3, 2023

A man in his 70s with past medical history of hypertension, dyslipidemia, CAD s/p left circumflex stent 2 years prior presented to the ED with worsening intermittent exertional chest pain relieved by rest. Yet this is rarely followed, and patient outcomes like this are the result once in a while. Am J Emerg Med. 2014;32:e5–e8.

Chest Pain 82

Chest Pain Cardiogenic Shock Ischemia Myocardial Infarction 82

Stroke: Vascular and Interventional Neurology

NOVEMBER 9, 2023

She was noted to have incidental left internal jugular (IJ) vein thrombosis for which anticoagulation was held in the setting of recent neurosurgical procedure and SAH. After the second treatment, she had improvement in speech and motor strength. Systolic blood pressure goal was gradually normalized. She was discharged home on HD20.ConclusionWe

Blood Pressure 40

Blood Pressure Stenosis Hemorrhage Thrombosis 40

DAIC

APRIL 2, 2025

Stone, MD Mount Sinai Health System tim.hodson Wed, 04/02/2025 - 15:26 March 31, 2025 Using intravascular imaging (IVI) to guide stent implantation during complex stenting procedures is safer and more effective for patients with severely calcified coronary artery disease than conventional angiography, the more commonly used technique.

Stents 40

Stents Stent Outcomes Coronary Angiogram 40

Open Heart

MARCH 3, 2025

Background Drug-eluting stents (DESs) have become the gold standard of coronary angioplasty since their inception in 2002. We aimed to compare outcomes between a broad range of second-generation DP-DES and BP-DES in an all-comer population. vs 57.5%, p=0.010), a greater average number of stents implanted per patient (1.72±0.92

Stents 52

Stents Stent Myocardial Infarction Angioplasty 52

Open Heart

JUNE 18, 2024

Background For high bleeding-risk patients (HBR) undergoing percutaneous coronary intervention (PCI), the LEADERS FREE (LF) and LEADERS FREE II (LF II) trials established the safety and efficacy of a stainless steel polymer-free biolimus-coated stent (SS-BCS) with 30 days of dual antiplatelet treatment (DAPT). to 9.2%) patients.

Stents 40

Stents Stent Outcomes Myocardial Infarction 40

Stroke: Vascular and Interventional Neurology

NOVEMBER 9, 2023

In order to improve treatment outcomes in these difficult cases, the use of stent‐assisted embolization has been attempted in endovascular treatment of intracranial aneurysms. Thromboembolic complications were observed in one patient, with the clinical outcome of death due to basilar stent thrombosis.

Aneurysm 40

Aneurysm Stents Stent Hemorrhage 40

Open Heart

OCTOBER 26, 2022

Background Bioresorbable vascular scaffolds (BVS) were designed to reduce the rate of late adverse events observed in conventional drug-eluting stents (DES) by dissolving once they have restored lasting patency. All other outcomes were statistically equivalent. to 1.70; p=0.01) resulting from high rates of TVMI and ID-TLR.

Stents 52

Stents Stent Coronary Artery Disease Myocardial Infarction 52

Circulation

NOVEMBER 11, 2024

The outcome was any 30-day event defined as death, stent thrombosis, major bleeding events, and composites of ischemic and bleeding events. There was no statistically significant difference in death or composite outcomes between groups (Table 2).

Thrombosis 40

Thrombosis Outcomes Stent Stents 40

Circulation

NOVEMBER 23, 2023

There was no difference in net adverse clinical outcomes and each component of coprimary cardiovascular end point. 3.30]) and subacute definite or probable stent thrombosis (0.58% and 0.17%; hazard ratio, 3.40 [95% CI, 1.26–9.23]) years; men, 76.6%; acute coronary syndrome, 75.0%). 1.45];Pnoninferiority=0.01).

Stents 40

Stents Stent Thrombosis Myocardial Infarction 40

Circulation

FEBRUARY 12, 2024

The 2 coprimary outcomes were target lesion revascularization and myocardial infarction. The secondary outcomes included ischemia-driven target lesion revascularization, target vessel myocardial infarction, death, cardiac death, target vessel revascularization, stent thrombosis, and major adverse cardiac events.

Ultrasound 67

Ultrasound Myocardial Infarction Thrombosis Stent 67

Circulation

OCTOBER 24, 2023

Background:Stopping aspirin within 1 month after implantation of a drug-eluting stent (DES) for ticagrelor monotherapy has not been exclusively evaluated for patients with acute coronary syndrome (ACS). Circulation, Ahead of Print. versus 3.4%; HR, 0.35 [95% CI, 0.20–0.61];P<0.001).Conclusions:This 0.61];P<0.001).Conclusions:This

Stents 40

Stents Stent Myocardial Infarction Thrombosis 40

Journal of Cardiovascular Pharmacology

MAY 2, 2024

Patient characteristics and clinical outcomes were collected via electronic medical record system. The primary outcome was major adverse cardiac and cerebrovascular event (MACCE), namely a composite of death from cardiovascular causes, myocardial infarction (MI), stroke, stent thrombosis within 12 month.

Outcomes 40

Outcomes Myocardial Infarction Thrombosis Academic 40

Circulation: Cardiovascular Interventions

MARCH 30, 2025

However, whether the addition of OCT to angiography to guide percutaneous coronary intervention (PCI) of complex lesions affects clinical outcomes is debated.Methods:A systematic search for randomized controlled trials (RCTs) was conducted using PubMed, Scopus, and Cochrane databases through September 2024.

Thrombosis 40

Thrombosis Myocardial Infarction Stent Stents 40

Open Heart

APRIL 15, 2022

Efficacy outcomes included the major adverse cardiovascular events outcome and safety outcomes included minor and major bleedings. We performed a frequentist network meta-analysis. Results Nine studies (n=35 441 patients) were included in the systematic review.

Myocardial Infarction 52

Myocardial Infarction Thrombosis Stent Stents 52

Open Heart

DECEMBER 29, 2022

Methods A search was conducted on five databases for randomised controlled trials (RCTs) conducted between 1 January 2000 and 17 July 2022, which included an ADP-specific platelet function assays and P2Y 12 antagonists as part of dual antiplatelet therapy (DAPT) and have reported the efficacy and/or safety outcomes.

Myocardial Infarction 52

Myocardial Infarction Thrombosis Stent Stents 52

All About Cardiovascular System and Disorders

APRIL 21, 2024

If the FFR normalizes after stenting, the restenosis rates at six months is less than 5%. Since the FFR wire can be used for guiding balloon catheters and stents, it is easy to make post procedure measurements without any additional effort. Routine FFR measurement probably lead to more judicious use of stents and improved outcomes.

Myocardial Infarction 52

Myocardial Infarction Stent Stents Coronary Artery Disease 52

Frontiers in Cardiovascular Medicine

NOVEMBER 21, 2024

There were no surgery-related deaths, no paraplegia,and all patients were successfully discharged.

Aortic 52

Aortic Thrombosis Aneurysm Stent 52

Journal of the American Heart Association

JANUARY 12, 2024

This study aimed to evaluate the clinical outcomes of intravascular imaging–guided PCI compared with angiography‐guided PCI.Methods and ResultsA random‐effects meta‐analysis was performed on the basis of the intention‐to‐treat principle. The primary outcomes were major adverse cardiac events, cardiac death, and all‐cause death.

Thrombosis 45

Thrombosis Stent Stents Outcomes 45

Cardiology Update

FEBRUARY 14, 2024

In the early years of percutaneous coronary intervention (PCI), studies indicated a heightened risk of major adverse cardiac events (MACE) in patients with reduced left ventricular ejection fraction (LVEF), involving outcomes such as death, Q-wave myocardial infarction (MI), stent thrombosis, and repeat revascularization.

Myocardial Infarction 52

Myocardial Infarction Coronary Artery Disease Thrombosis Research 52

Coronary Artery Disease Journal

AUGUST 22, 2024

Other outcomes were comparable in both groups. Major ischemic outcomes were similar. Data were extracted from published reports and quality assessment was performed per Cochrane recommendations. Major bleeding [hazard ratio 0.47; 95% confidence interval (CI), 0.37–0.61; 0.61; P < 0.001], NACE (hazard ratio 0.71; 95% CI, 0.56–0.90;

Myocardial Infarction 40

Myocardial Infarction Thrombosis Stent Stents 40

Circulation

NOVEMBER 11, 2024

A meta-analysis was performed on primary outcomes of major adverse cardiac events (MACE) and all-cause mortality. A random-effects model was used for outcomes with high heterogeneity.Results:We included 4 RCTs with 3173 patients comparing FFR-guided CR with culprit-only PCI in patients with STEMI and multivessel coronary artery diseases.

Coronary Artery Disease 40

Coronary Artery Disease Myocardial Infarction STEMI Thrombosis 40

Cardiology Update

APRIL 9, 2024

The percent change from baseline in fasting triglycerides (TG) at six months served as the primary outcome measure. The percent change from baseline in fasting TG at six months served as the primary outcome measure. Among patients with HFpEF, those who received the shunt experienced poor outcomes than those who did not.

Angina 52

Angina Myocardial Infarction Aortic valve Coronary Artery Disease 52

Frontiers in Cardiovascular Medicine

NOVEMBER 28, 2024

We included major adverse cardiovascular events (MACE), myocardial infarction (MI), cardiac death and other outcome indicators. ConclusionsCompared with the non-IVUS-guided group, IVUS-guided stent implantation may be more effective for patients with complex CAD.Systematic Review RegistrationPROSPERO [CRD42024531366].

Stents 59

Stents Stent Coronary Artery Disease Myocardial Infarction 59

Frontiers in Cardiovascular Medicine

NOVEMBER 19, 2024

BackgroundWhile several studies have explored the outcomes of transcatheter interventions for modified Blalock–Taussig shunts (MBTSs) in a broad range of congenital heart diseases, none have specifically examined the interventions in patients with hypoplastic left heart syndrome (HLHS) who underwent Norwood palliation (NP).MethodsThis

Thrombosis 59

Thrombosis Stent Stents Congenital Heart Disease 59

Frontiers in Cardiovascular Medicine

DECEMBER 22, 2024

We describe the single center experience of a series of patients treated with endovascular stent grafting for large aneurysms after previous surgery for CoA.MethodsThis series involves 12 consecutive patients treated with endovascular stent grafting from April 2003 to January 2022 for late aneurysm at the site of previous surgical repair for CoA.

Aneurysm 52

Aneurysm Aortic Stent Stents 52

Dr. Smith's ECG Blog

MARCH 8, 2025

After stent deployment, we often see improvement in the ST-T within seconds or minutes. Here is the final angiogram following placement of a stent in the ostial RCA. 2:04 PM, post stent deployment You can see that even after complete restoration of flow, the ECG still looks terrible, V most of all.

Cardiomyopathy 75

Cardiomyopathy Myocardial Infarction Defibrillator Bradycardia 75